Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Taclix 0.03% Ointment

Prescription Icon
Prescription Required

Marketer

Biochemix Health Care Pvt. Ltd.

Salt Composition

Tacrolimus (0.03% w/w)

Overview Taclix 0.03% Ointment

Eczema (atopic dermatitis) is treated with Taclix 0.03% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply Taclix 0.03% Ointment topically, 2–4 times daily to affected areas, or as directed by your physician. Gently and evenly spread the ointment until absorbed. Avoid overuse and avoid covering treated areas with bandages. Consult your doctor if symptoms worsen or show no improvement after two weeks. Possible side effects include redness (erythema), headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Use during pregnancy or breastfeeding is generally not advised unless deemed essential by a healthcare professional.

Uses of Taclix 0.03% Ointment

Managing atopic dermatitis

Major Benefits of Taclix 0.03% Ointment:

Apply this medication solely to the skin's surface. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application guidelines. Before applying, ensure the affected area is clean and dry; then, gently rub in the ointment.

Common Side effects of Taclix 0.03% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Taclix 0.03% Ointment:

Apply this medication solely to the skin's surface. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines prior to use. Ensure the affected area is clean and dry before gently rubbing in the ointment.

How Taclix 0.03% Ointment works:

Taclix 0.03% ointment, an immunosuppressive agent, reduces skin inflammation (redness and swelling) by inhibiting the action of specific immune cells. This alleviates itching and enhances the appearance of atopic dermatitis rashes.

SAFETY ADVICE

AlcoholAlcoholNone

No drug interaction detected.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Taclix 0.03% Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Using Taclix 0.03% Ointment while breastfeeding appears to pose minimal risk. Available human data indicate insignificant danger to the infant.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Taclix 0.03% Ointment :

For forgotten Taclix 0.03% Ointment applications, use it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed application and resume your usual dosing routine.

Facts to Know About Taclix 0.03% Ointment

LabelValue
Type of Compound Large-ring lactone antibiotics
Potential for Dependence None.
Type of Treatment Cancer therapeutics
Mechanism of Action Drugs suppressing the immune system: Calcineurin inhibitor class

FAQs on Taclix 0.03% Ointment

Taclix 0.03% Ointment is an immunomodulatory medication that primarily reduces immune system activity. It's indicated for treating moderate to severe atopic dermatitis in adults unresponsive to, or experiencing adverse effects from, steroid treatments. Atopic dermatitis involves an overactive skin immune response, resulting in inflamed, itchy, and dry skin. Taclix 0.03% Ointment modifies this aberrant immune reaction, thus alleviating inflammation and pruritus.
Topical application of Taclix 0.03% Ointment can induce localized skin reactions including irritation, burning, and pruritus. These effects typically range from mild to moderate and generally subside within seven days of treatment initiation. Erythema is frequently observed, accompanied by warmth, discomfort, paresthesia, and rash at the application site. Treatment is associated with a heightened risk of folliculitis, herpes labialis, acne breakouts, and disseminated herpes simplex infections.
Taclix 0.03% Ointment provides safe and effective short-term atopic dermatitis treatment, exhibiting superior safety compared to other immunosuppressants. Topical application results in minimal systemic absorption, leading to reduced adverse effects relative to oral administration.
Taclix 0.03% Ointment is not a controlled substance and poses no risk of abuse. Controlled substances, by definition, have abuse potential, requiring authorization from both medical professionals and regulatory bodies for dispensing.
Prolonged application of Taclix 0.03% Ointment may elevate the likelihood of developing lymph node cancers, specifically lymphoma. Limited research indicates a correlation between the use of Taclix 0.03% Ointment or comparable treatments and the occurrence of skin cancer or lymphoma in a small number of patients. Seek medical advice if Taclix 0.03% Ointment is needed for over six weeks, or if your eczema symptoms show no improvement or worsen during treatment.
Taclix 0.03% Ointment does not contain steroids. This medication modifies immune system function and treats eczema, particularly atopic dermatitis. A key benefit is its avoidance of skin thinning (atrophy) and other adverse effects associated with steroid use.
Taclix 0.03% Ointment
129
MRP 157
17% off